Revelle Aesthetics Aveli
Cellulite treatment · Handheld light-guided subcision
At a glance
- New price
- Not published
- FDA status
- Supplies & recurring costs
- Supply details not yet documented.
Sources and verified data on file
Data on file
- Recurring consumables
- Not verified
- Used asking prices
- Not verified
- This panel shows a per-treatment supply cost only when a recorded figure has a dated source.
- Bottle prices and estimates may still appear under Treatment & running costs.
- The calculator may include a labeled planning estimate. Review it or enter your own allowance; missing data never means $0.
Figures are reference points, not current offers.
Read FDA-cleared indicationsExact wording from 2 FDA records
K212399 (Nc8, Inc., 2021)
Avéli is indicated for temporary reduction in the appearance of cellulite in the buttocks and thigh areas of adult females as supported by clinical data demonstrating benefits through three months of observation.
Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.
K221336 (Revelle Aesthetics, Inc., 2022)
Av6li is indicated for long-term reduction in the appearance of cellulite in the buttocks and thigh areas of adult females as supported by clinical data demonstrating treatment benefits through one year of observation.
Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.
Page updated: August 6, 2026 · How we verify
No new-equipment price range is published for this model. Ask the seller for a dated, itemized quote covering configuration, training and service.
Price sourcesSources, dates and configurations
No price sources are documented yet. Ask the seller for a current, itemized quote.
Key factsCompany, specifications and verification dates
| Manufacturer | Revelle Aesthetics |
|---|---|
| Company | Not published |
| Parent company | Revelle Aesthetics |
| Brand owner | Revelle Aesthetics |
| Built by (OEM) | Revelle Aesthetics Inc. |
| Category | Body Contouring |
| Technology | Handheld light-guided subcision |
| FDA status | FDA Cleared |
| 510(k) citation | K212399, K221336 |
| New price range | Not published |
| Used asking range | Not published |
| Consumables | Not published |
| Launch year | 2022 |
| Pricing | Not published |
| Manufacturer-source documents checked | Not published |
Overview
Per-procedure disposable wand, cellulite dimple release
FDA & regulatory detailClearance timeline, authorization route and citation notes
FDA-cleared indications (verbatim)
K212399 (Nc8, Inc., 2021)
Avéli is indicated for temporary reduction in the appearance of cellulite in the buttocks and thigh areas of adult females as supported by clinical data demonstrating benefits through three months of observation.
Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.
K221336 (Revelle Aesthetics, Inc., 2022)
Av6li is indicated for long-term reduction in the appearance of cellulite in the buttocks and thigh areas of adult females as supported by clinical data demonstrating treatment benefits through one year of observation.
Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.
Marketed for
Cellulite treatment — Handheld light-guided subcision
Marketing claims are the manufacturer's own and are not the same as a cleared indication.
Parent company: Revelle Aesthetics
Legal manufacturer: Revelle Aesthetics Inc. (United States)
Applicant on the FDA record
Nc8, Inc.The applicant named on the FDA record can differ from the brand shown on the device.
Regulatory data comes from public FDA records and may lag recent updates. Confirm the applicable status and documentation before purchase.
Treatment & running costs
Treatments
Sessions & timing
No treatment schedule documented yet.
What practices charge
No sourced treatment price on file.
Supplies & recurring costs
Consumable costs are not documented yet.
Annual service & support
No annual service cost documented yet.
Warranty & serviceWhat to confirm in writing before you buy
Before buying new or used, confirm in writing:
- Current warranty coverage
- Included training
- Service terms
Chains using this device
A chain listing does not establish availability at every location.
No confirmed chain deployments recorded yet.
Owner & operator reviews
Write a reviewNo owner or operator reviews yet. Be the first →
Current alternatives
Current catalog models to research. Confirm availability and configuration with the supplier.
History1 tracked change
Every tracked change to pricing, lifecycle status, FDA data and warranty terms — newest first.
August 1, 2026
Record created
Added to The Aesthetic Index — August 2026
Source: The Aesthetic Index editorial
Cite this data: The Aesthetic Index, "Revelle Aesthetics Aveli — pricing, FDA status and cost to own", aestheticindex.co (accessed September 24, 2026).
Get the full State of Aesthetic Devices 2026 report
A catalog of US-marketed aesthetic and wellness devices — preview it free.
Device and company names are trademarks of their respective owners. The Aesthetic Index is not affiliated with or endorsed by any manufacturer, distributor or lender named here, except as disclosed. Price figures are references, not current offers. Check each device’s source notes. Not medical, legal or regulatory advice.